ArticleCureus2026
Beyond the Kidneys: Multisystem Systemic Lupus Erythematosus Presenting With Cardiac Tamponade, Class V Lupus Nephritis, Dysphagia, and Peripheral Neurologic Manifestations.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by immune dysregulation, immune complex deposition, and multisystem inflammation with highly variable clinical manifestations. Although lupus nephritis and serositis are common complications, the simultaneous occurrence of biopsy-proven membranous lupus nephritis, cardiac tamponade, polyserositis, dysphagia, and peripheral neurologic manifestations is uncommon and presents significant diagnostic and therapeutic challenges. We present the case of a 37-year-old Hispanic woman with newly diagnosed SLE who developed progressive dysphagia, peripheral sensory deficits, pleural and pericardial involvement complicated by cardiac tamponade, ascites, and biopsy-proven International Society of Nephrology/Renal Pathology Society (ISN/RPS) Class V lupus nephritis. Laboratory evaluation demonstrated a homogeneous antinuclear antibody titer greater than 1:2560, elevated anti-double-stranded DNA antibodies, hypocomplementemia, and approximately 2 g/day of proteinuria. Cross-sectional imaging demonstrated extensive serosal involvement, including bilateral pleural effusions, a large pericardial effusion, pelvic ascites, and perihepatic free fluid. Renal biopsy demonstrated ISN/RPS Class V membranous lupus nephritis with subepithelial, intramembranous, and mesangial immune-type electron-dense deposits and near-global podocyte foot process effacement on electron microscopy. The patient required urgent pericardiocentesis and multidisciplinary management with pulse corticosteroids, hydroxychloroquine, mycophenolate mofetil, and belimumab. Following treatment, her clinical condition improved with resolution of cardiac tamponade and stabilization of her multisystem disease. This case highlights the protean nature of SLE and emphasizes the importance of recognizing simultaneous renal, cardiac, neurologic, gastrointestinal, and serosal involvement. Early multidisciplinary evaluation and prompt immunosuppressive therapy are essential to preventing irreversible organ damage and improving clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.